Biallelic mutations in NRROS cause an early onset lethal microgliopathy
Open Access
- 25 February 2020
- journal article
- research article
- Published by Springer Nature in Acta Neuropathologica
- Vol. 139 (5) , 947-951
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- LRRC33 is a novel binding and potential regulating protein of TGF-β1 function in human acute myeloid leukemia cellsPLOS ONE, 2019
- Homozygous Mutations in CSF1R Cause a Pediatric-Onset Leukoencephalopathy and Can Result in Congenital Absence of MicrogliaThe American Journal of Human Genetics, 2019
- Microglial TREM2/DAP12 Signaling: A Double-Edged Sword in Neural DiseasesFrontiers in Cellular Neuroscience, 2018
- Biallelic interferon regulatory factor 8 mutation: A complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulationJournal of Allergy and Clinical Immunology, 2018
- Human TGF-β1 deficiency causes severe inflammatory bowel disease and encephalopathyNature Genetics, 2018
- Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndromeJournal of Experimental Medicine, 2016
- USP18 lack in microglia causes destructive interferonopathy of the mouse brainThe EMBO Journal, 2015
- NRROS negatively regulates reactive oxygen species during host defence and autoimmunityNature, 2014
- Epigenetically modulated LRRC33 acts as a negative physiological regulator for multiple Toll-like receptorsJournal of Leukocyte Biology, 2014
- IRF8Mutations and Human Dendritic-Cell ImmunodeficiencyNew England Journal of Medicine, 2011